Evaluation of changes in guidelines for medication management of stable chronic obstructive pulmonary disease

Journal of Evaluation in Clinical Practice

Volumn 19, Issue 5, 2013, Pages 953-960

  Lin, Fang Ju ^a   Lee, Todd A ^a   Wong, Pei Shieen ^a   Pickard, A Simon ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

COPD; Global Initiative for Chronic Obstructive Lung Disease; guidelines; level of evidence

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; ANTIOXIDANT; ANTITUSSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; METHYLXANTHINE; MUCOLYTIC AGENT; NARCOTIC AGENT; PHOSPHODIESTERASE IV INHIBITOR; RESPIRATORY STIMULANT AGENT; VACCINE; VASODILATOR AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CONTROL; EVIDENCE BASED MEDICINE; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GUIDELINE; HUMAN; MEDICATION THERAPY MANAGEMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

COPD; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; GUIDELINES; LEVEL OF EVIDENCE;

CONSENSUS; EVIDENCE-BASED MEDICINE; HUMANS; MEDICATION THERAPY MANAGEMENT; PATIENT ACUITY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY SYSTEM AGENTS;

EID: 84885022105     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2012.01892.x     Document Type: Article

References (13)

1. Global Initiative for Chronic Obstructive Lung Disease (2001) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Available at: http://www.goldcopd. org/uploads/users/files/GOLDWkshp2001.pdf (last accessed 11 November 2011).
2. Global Initiative for Chronic Obstructive Lung Disease (2011) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Available at: http://www.goldcopd.org/uploads/users/files/ GOLD-Report-2011.pdf (last accessed 29 December 2011).
3. Institute of Medicine (U.S.) (1992) Guidelines for Clinical Practice: From Development to Use. Washington, DC: National Academy Press.
4. Smith, B. J., Hender, K., Frith, P., Crockett, A. J., Cheok, F., &, Spedding, S., (2003) Systematic assessment of clinical practice guidelines for the management of chronic obstructive pulmonary disease. Respiratory Medicine, 97 (1), 37-45.
5. Global Initiative for Chronic Obstructive Lung Disease (2010) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Available at: http://www.goldcopd.org/uploads/users/files/ GOLDReport-April112011.pdf (last accessed 11 November 2011).
6. Heffner, J. E., &, Ellis, R., (2003) The guideline approach to chronic obstructive pulmonary disease: how effective? Respirotary Care, 48 (12), 1257-1266. discussion 1267-1258.
7. Roche, N., Lepage, T., Bourcereau, J., &, Terrioux, P., (2001) Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. European Respiratory Journal, 18 (6), 903-908.
8. Schumock, G. T., &, Pickard, A. S., (2009) Comparative effectiveness research: relevance and applications to pharmacy. American Journal of Health-System Pharmacy, 66 (14), 1278-1286.
9. Tricoci, P., Allen, J. M., Kramer, J. M., Califf, R. M., &, Smith, S. C., Jr (2009) Scientific evidence underlying the ACC/AHA clinical practice guidelines. Journal of the American Medical Association, 301 (8), 831-841.
10. Roos, M., Brodbeck, J., Sarkozy, A., Chierchia, G. B., De Asmundis, C., &, Brugada, P., (2011) A critical analysis of the scientific evidence behind international guidelines related to cardiac arrhythmias. Circulation, 4 (2), 202-210.
11. Vandvik, P. O., Lincoff, A. M., Gore, J. M., Gutterman, D. D., Sonnenberg, F. A., Alonso-Coello, P., Akl, E. A., Lansberg, M. G., Guyatt, G. H., &, Spencer, F. A., (2012) Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141 (2 Suppl), e637S-e668S.
12. Anderson, J. L., Adams, C. D., Antman, E. M., et al. (2011) 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 123 (18), e426-e579.
13. Atkins, D., Best, D., Briss, P. A., et al. (2004) Grading quality of evidence and strength of recommendations. BMJ (Clinical Research Ed.), 328 (7454), 1490-1494.